Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL2000185	注射用重组人肿瘤坏死因子相关凋亡诱导配体–三聚体融合蛋白	Lyophilized	Biological Products(1)	New Drug Application	2020-07-04	四川三叶草生物制药有限公司	Sichuan Clover Biopharmaceuticals Co Ltd	In Review	2020-07-02	view
CXSL1900015	注射用重组人肿瘤坏死因子相关凋亡诱导配体–三聚体融合蛋白	Lyophilized	Biological Products(1)	New Drug Application	2019-02-22	四川三叶草生物制药有限公司	Sichuan Clover Biopharmaceuticals Co Ltd	In Review	2019-02-21	view
CXSL2000184	注射用重组人肿瘤坏死因子相关凋亡诱导配体–三聚体融合蛋白	Lyophilized	Biological Products(1)	New Drug Application	2020-07-01	四川三叶草生物制药有限公司	Sichuan Clover Biopharmaceuticals Co Ltd	In Review	2020-06-29	view
CXSL1900034	注射用重组人肿瘤坏死因子相关凋亡诱导配体–三聚体融合蛋白	Lyophilized	Biological Products(1)	New Drug Application	2019-04-19	四川三叶草生物制药有限公司	Sichuan Clover Biopharmaceuticals Co Ltd	In Review	2019-04-18	view
CXSL1900031	注射用重组人肿瘤坏死因子相关凋亡诱导配体–三聚体融合蛋白	Lyophilized	Biological Products(1)	New Drug Application	2019-04-01	四川三叶草生物制药有限公司	Sichuan Clover Biopharmaceuticals Co Ltd	In Review	2019-03-29	view
CXSB2101038	注射用重组人肿瘤坏死因子相关凋亡诱导配体–三聚体融合蛋白	Lyophilized	Biological Products(1)	Supplementary Application	2021-09-02		Sichuan Clover Biopharmaceuticals Co Ltd			view